Kairos Pharma, Ltd. (KAPA)

NYSEAMERICAN: KAPA · Real-Time Price · USD

0.2900

-0.0051 (-1.73%)

At close: Aug 21, 2026, 4:00 PM EDT

0.2653

-0.0247 (-8.52%)

After-hours: Aug 21, 2026, 8:00 PM EDT

Kairos Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.63	4.49	1.27	0.09	0.44	0.07
Cash & Short-Term Investments	2.63	4.49	1.27	0.09	0.44	0.07
Cash Growth	-13.45%	253.07%	1267.74%	-78.72%	498.63%	410.20%
Prepaid Expenses	0.14	0.05	0.04	0.01	-	-
Other Current Assets	0.41	0.85	2.86	-	-	-
Total Current Assets	3.17	5.39	4.17	0.1	0.44	0.07
Other Intangible Assets	-	0.06	0.22	0.38	0.54	0.7
Long-Term Deferred Charges	1.28	1.09	1.38	0.48	0.06	-
Total Assets	4.46	6.54	5.77	0.97	1.04	0.78

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.27	0.2	0.99	2.4	1.63	1.55
Short-Term Debt	-	-	-	0	0	0.39
Total Current Liabilities	0.27	0.2	0.99	2.41	1.63	1.94
Long-Term Debt	-	-	-	0.64	0.58	-
Total Liabilities	0.27	0.2	0.99	3.04	2.22	1.94

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.01	0.01	0.01	0.1
Additional Paid-In Capital	21.47	20.58	13.58	4.12	3.21	2.08
Retained Earnings	-17.3	-14.26	-8.82	-6.21	-4.4	-3.35
Shareholders' Equity	4.19	6.34	4.78	-2.08	-1.18	-1.17
Total Liabilities & Equity	4.46	6.54	5.77	0.97	1.04	0.78

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	-	0.64	0.59	0.39
Net Cash (Debt)	2.63	4.49	1.27	-0.55	-0.15	-0.32
Net Cash Growth	-13.45%	253.07%	-	-	-	-
Net Cash Per Share	0.13	0.24	0.11	-0.05	-0.01	-0.04
Filing Date Shares Outstanding	23.7	21.41	16.69	10.56	10.33	12.08
Total Common Shares Outstanding	21.42	20.82	13.74	10.56	10.33	12.08
Working Capital	2.91	5.19	3.18	-2.3	-1.2	-1.87
Book Value Per Share	0.20	0.30	0.35	-0.20	-0.11	-0.10
Tangible Book Value	4.19	6.28	4.55	-2.46	-1.72	-1.87
Tangible Book Value Per Share	0.20	0.30	0.33	-0.23	-0.17	-0.15

SEC Filings: 10-K · 10-Q